Association Between Interleukin-6 Gene Polymorphism and Severity of Coronary Artery Disease in Patients with Diabetes

References

• Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021;11(2):169–177. doi:10.2991/jegh.k.201217.001
   PubMed Web of Science ®Google Scholar
• Canto JG, Kiefe CI, Rogers WJ, et al. Number of Coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011;306(19):2120–2127. doi:10.1001/jama.2011.1654
   PubMed Web of Science ®Google Scholar
• Badimon L, Padró T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care. 2012;1(1):60–74. doi:10.1177/2048872612441582
   PubMedGoogle Scholar
• Su JH, Luo MY, Liang N, et al. Interleukin-6: a Novel Target for Cardio-Cerebrovascular Diseases. Front Pharmacol. 2021;12:745061. doi:10.3389/fphar.2021.745061
   PubMed Web of Science ®Google Scholar
• Shanker J, Kakkar VV. Implications of genetic polymorphisms in inflammation-induced atherosclerosis. Open Cardiovasc Med J. 2010;4:30–37.
   PubMedGoogle Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• Omoigui S. The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immun Ageing. 2007;4:1. doi:10.1186/1742-4933-4-1
   PubMedGoogle Scholar
• Fanola CL, Morrow DA, Cannon CP, et al. Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial. J Am Heart Assoc. 2017;6(10):e005637. doi:10.1161/JAHA.117.005637
   PubMed Web of Science ®Google Scholar
• Zheng GH, Chen HY, Xiong SQ. Polymorphisms of −174G>C and −572G>C in the interleukin 6 (IL-6) gene and Coronary heart disease risk: a meta-analysis of 27 research studies. PLoS One. 2012;7(4):e34839. doi:10.1371/journal.pone.0034839
   PubMed Web of Science ®Google Scholar
• Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9:767–780. doi:10.1111/j.1463-1326.2006.00655.x
   PubMed Web of Science ®Google Scholar
• Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–1335. doi:10.2522/ptj.20080008
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327–334. doi:10.2174/1874192401004020030
   PubMed Web of Science ®Google Scholar
• Akash MS, Shen Q, Rehman K, Chen S. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci. 2012;101:1647–1658. doi:10.1002/jps.23057
   PubMed Web of Science ®Google Scholar
• Lu QK, Zhang JT, Zhao N, Wang HY, Tong QH, Wang SL. Association of IL-6 Gene (−174 and −572 G/C) polymorphisms with proliferative diabetic retinopathy of type 2 diabetes in a Chinese population. Ophthalmic Res. 2017;58(3):162–167. doi:10.1159/000475670
   PubMed Web of Science ®Google Scholar
• Ayelign B, Negash M, Andualem H, et al. Association of IL-10 (− 1082 A/G) and IL-6 (− 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population. BMC Endocr Disord. 2021;21:70. doi:10.1186/s12902-021-00738-1
   PubMed Web of Science ®Google Scholar
• Shoily SS, Ahsan T, Fatema K, Sajib AA. Common genetic variants and pathways in diabetes and associated complications and vulnerability of populations with different ethnic origins. Sci Rep. 2021;11(1):7504. doi:10.1038/s41598-021-86801-2
   PubMed Web of Science ®Google Scholar
• Liu K, Xie Y, Zhao Q, et al. Polymorphisms and gene-gene interaction in AGER/IL6 pathway might be associated with diabetic ischemic heart disease. J Pers Med. 2022;12(3):392.
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747–753. doi:10.1038/nature08494
   PubMed Web of Science ®Google Scholar
• Caraballo C, Desai NR, Mulder H, et al. Clinical Implications of the New York heart association classification. J Am Heart Assoc. 2019;8(23):e014240. doi:10.1161/JAHA.119.014240
   PubMed Web of Science ®Google Scholar
• Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 1979;59(3):607–609. doi:10.1161/01.CIR.59.3.607
   PubMedGoogle Scholar
• World Health Organization. Cardiovascular diseases Credits. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. Accessed November 04, 2023.
   Google Scholar
• Windecker S, Kolh P. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619.
   PubMed Web of Science ®Google Scholar
• Sianos G, Morel M-A, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219–227.
   PubMedGoogle Scholar
• Sen S, Burmeister M. Hardy-Weinberg analysis of a large set of published association studies reveals genotyping error and a deficit of heterozygotes across multiple loci. Hum Genomics. 2008;3(1):36–52. doi:10.1186/1479-7364-3-1-36
   PubMedGoogle Scholar
• Mormile R. Multiple sclerosis and susceptibility to cardiovascular diseases: implications of ethnicity-related interleukin-17A gene polymorphism? Med Hypotheses. 2015;85(3):365–366.
   PubMed Web of Science ®Google Scholar
• Qi X, Bai F, You C, Guo X, Shi L, Hu Z. 高分辨率融解曲线技术检测冠心病患者IL-1β和IL-1Ra基因多态性[High-resolution melting technology for detecting genetic polymorphisms of IL-1β and IL-1Ra in patients with coronary artery disease]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015;31(6):816–820. Chinese.
   PubMedGoogle Scholar
• Song Y, Gu HD, He Y, Wang JW. Role of IL-6 polymorphism on the development of cardiovascular events and coronary artery disease in patients receiving hemodialysis. Genet Mol Res. 2015;14(1):2631–2637. doi:10.4238/2015.March.30.23
   PubMed Web of Science ®Google Scholar
• Wang S, Dai YX, Chen LL, et al. Effect of IL-1β, IL-8, and IL-10 polymorphisms on the development of myocardial infarction. Genet Mol Res. 2015;14(4):12016–12021. doi:10.4238/2015.October.5.14
   PubMed Web of Science ®Google Scholar
• Zou L, Zhao H, Gong X, et al. The association between three promoter polymorphisms of IL-1 and stroke: a meta-analysis. Gene. 2015;567(1):36–44.
   PubMed Web of Science ®Google Scholar
• Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275(24):18138–18144. doi:10.1074/jbc.M000379200
   PubMed Web of Science ®Google Scholar
• Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986;324(6092):73–76. doi:10.1038/324073a0
   PubMed Web of Science ®Google Scholar
• Simpson RJ, Hammacher A, Smith DK, Matthews JM, Ward LD. Interleukin-6: structure-function relationships. Protein Sci. 1997;6(5):929–955.
   PubMed Web of Science ®Google Scholar
• Batra G, Ghukasyan Lakic T, Lindbäck J, et al. STABILITY Investigators. Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome. JAMA Cardiol. 2021;6(12):1440–1445.
   PubMed Web of Science ®Google Scholar
• Held C, White HD, Stewart RAH, et al. STABILITY Investigators. Inflammatory Biomarkers Interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017;6(10):e005077. doi:10.1161/JAHA.116.005077
   PubMed Web of Science ®Google Scholar
• Elsenberg EH, Sels JE, Hillaert MA, et al. Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease. Atherosclerosis. 2013;231(2):346–351. doi:10.1016/j.atherosclerosis.2013.09.036
   PubMed Web of Science ®Google Scholar
• Roy N, Rosas SE. IL-6 is associated with progression of coronary artery calcification and mortality in incident dialysis patients. Am J Nephrol. 2021;52(9):745–752. doi:10.1159/000518652
   PubMed Web of Science ®Google Scholar
• Li L, Li E, Zhang LH, Jian LG, Liu HP, Wang T. IL-6-174G/C and IL-6-572C/G polymorphisms are associated with increased risk of coronary artery disease. Genet Mol Res. 2015;14(3):8451–8457.
   PubMed Web of Science ®Google Scholar
• Wang K, Dong PS, Zhang HF, Li ZJ, Yang XM, Liu H. Role of interleukin-6 gene polymorphisms in the risk of coronary artery disease. Genet Mol Res. 2015;14(2):3177–3183. doi:10.4238/2015.April.10.29
   PubMed Web of Science ®Google Scholar
• Salari N, Mansouri K, Hosseinian-Far A, et al. The effect of polymorphisms (174G> C and 572C> G) on the Interleukin-6 gene in coronary artery disease: a systematic review and meta-analysis. Genes Environ. 2021;43(1):1. doi:10.1186/s41021-021-00172-8
   PubMed Web of Science ®Google Scholar
• Fu HX, Zhang JY, Li GS, Li Y, Xu JL, Zhao ZN. Association study of interleukin-6 gene −572C/G polymorphism with susceptibility to myocardial infarction. Chin J Med Genet. 2006;23(3):245–249.
   Google Scholar
• Hongmei Y, Yongping J, Jiyuan L. Interleukin-6 polymorphisms and risk of coronary artery diseases in a Chinese population: a case-control study. Pak J Med Sci. 2016;32(4):880–885. doi:10.12669/pjms.324.9908
   PubMed Web of Science ®Google Scholar